Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Jeremy the seven-month-old wallaby was taken to a vets on the Isle of Man after being discovered by walkers beside his dead mother.
It's been confirmed that there will be no big screens erected in the Ukrainian capital for away Liverpool supporters to watch the match.
As the world watched, Manchester came together in a show of solidarity and hope after tragedy. These are stories from the mourning crowd: